Remote Monitoring of COPD Patients Experiencing an Acute Exacerbation Through Health Evaluations Using Wearable Mobile Technology

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Chronic obstructive pulmonary disease (COPD) causes about 3 million deaths annually and significantly burdens healthcare systems, costing the EU 38.6 billion euros, largely due to frequent hospitalizations triggered by acute exacerbations (AECOPD). AECOPD worsens patient health, accelerates lung decline, and lowers quality of life, highlighting the need for early detection. Moreover, these AECOPD events happen in an out-hospital setting and are therefore, not preventable. A clear clinical and quality-of-life need arises to reduce AECOPD-related events and consequent hospitalizations. Mobile health (mHealth) offers a solution by monitoring patients remotely using unobtrusive wearable devices. Parameters like peripheral oxygen saturation (SpO2) and respiratory rate can detect and predict exacerbations. However, no data at home is available of AECOPD events and robust predictive algorithms are lacking. This study aims to monitor vital parameters at home, tracking physical activity, pulse, respiratory rate, SpO2, sleep, and skin temperature from the moment of ER admission until three months post-discharge. Data will be used to gain insight in the COPD progression following an AECOPD event and to construct a predictive model, enabling timely intervention, reducing hospitalizations, and improving outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Provide signed and dated informed consent

• Adults older than 18 years of age

• Previously diagnosed with COPD

• Speak and understand the Dutch language

• Need for hospitalization

Locations
Other Locations
Belgium
Ziekenhuis Oost-Limburg
RECRUITING
Genk
Contact Information
Primary
Ruben Knevels, MSc
ruben.knevels@zol.be
+3289804029
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 20
Treatments
Experimental: Patients admitted with an acute COPD exacerbation
Wearable mobile device
Sponsors
Leads: David Ruttens

This content was sourced from clinicaltrials.gov